drugset / Trial / NCT01825707

AME Study of [14C]-YH4808 in Healthy Male Subjects

NCT01825707

Phase 1 Completed 8 enrolled Yuhan Corporation
NaSingle-groupOpen-label

Summary

The purpose of this study is to determine the absorption, metabolism, and excretion (AME) kinetics of YH4808 and to determine and characterize metabolites present in plasma, urine, and feces in man following a single dose of \[14C\] YH4808 200 mg (\~100 µCi ±20 µCi) administered as a single oral dose.

Timeline

Start
2013-01
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject YH4808 Other / unclassified 200 mg Oral

Indications

No indication recorded.